Letter to the Editor | Volume: 9, Issue: 1, January, 2019

Hepatotoxicity associated with statins: Role of drug interactions

Estrella Martínez-Gómez Laura Sanz Villanueva Cecilio Parra-Martínez Inmaculada Medina-Cáliz M. Isabel Lucena   

Open Access   

Published:  Feb 04, 2019

DOI: 10.7324/JAPS.2019.90120

No abstract is available.

Keyword:     Hepatotoxicity statins drug interactions.


Martínez-Gómez E, Villanueva LS, Parra-Martínez C, Medina-Cáliz I, Lucena MI. Hepatotoxicity associated with statins: Role of drug interaction. J Appl Pharm Sci, 2019; 9(01):147–148.

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, González-Grande R, Pizarro A, Durán JA, Jiménez M. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology, 2005; 129(2):512–21.

Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol, 2012; 56(2):374–80.

Carrascosa MF, Salcines-Caviedes JR, Lucena MI, Andrade RJ. Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity? J Hepatol, 2014; 62(3):751–52; doi:10.1016/j.jhep.2014.11.019

Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI. Drug-induced liver injury: interactions between drug properties and host factors. J Hepatol, 2015; 63(2):503–14; doi:10.1016/j.jhep.2015.04.016

García-Cortés M, Stephens C, Lucena MI, Fernández- Castañer A, Andrade RJ. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol, 2011; 55(3):683–91.

Lammert C, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology, 2008; 47(6):2003–9.

Perdices EV, Medina-Cáliz I, Hernando S, Ortega A, Martín- Ocaña F, Navarro JM, Peláez G, Castiella A, Hallal H, Romero-Gómez M, González-Jiménez A. Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish hepatotoxicity registry [Hepatotoxicidad Asociada Al Consumo de Estatinas: Análisis de Los Casos Incluidos En El Registro Español de Hepatotoxicidad]. Rev Esp Enferm Dig, 2014; 106(4):246–54.

Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina- Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero–Gómez M, Jimenez–Perez M. Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology, 2014; 147(1):109–118.e5; doi:10.1053/j. gastro.2014.03.050.

Thotakura S, Singh A, Khera K, Chauhan S, Devasia T. Atorvastatin-induced hepatotoxicity, increased by clopidogrel stress on CYP450 enzyme: understanding the mechanism through a case. J Appl Pharm Sci, 2018; 8(4):168–70.

Article Metrics

523 Absract views 36 PDF Downloads 559 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required